About Pedra
Pedra is a company based in Singapore (Singapore) founded in 2013.. Pedra has raised $4.7 million across 2 funding rounds from investors including M&L Group, SEEDS Capital and NTUitive. Pedra offers products and services including Xauron Perfusion System. Pedra operates in a competitive market with competitors including Podimetrics, VOTIS, Thermetrix, Mimosa Diagnostics and Celsius Health, among others.
- Headquarter Singapore, Singapore
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Pedra Technology Pte. Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.7 M (USD)
in 2 rounds
-
Latest Funding Round
$4.7 M (USD), Series A
Sep 22, 2020
-
Investors
M&L Group
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pedra
Pedra offers a comprehensive portfolio of products and services, including Xauron Perfusion System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides real-time quantitative monitoring for tissue perfusion in medical procedures
Funding Insights of Pedra
Pedra has successfully raised a total of $4.7M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.7 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $4.7M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Series A - Pedra | Valuation | M&L Healthcare | |
| Jun, 2013 | Amount | Grant - Pedra | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pedra
Pedra has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include M&L Group, SEEDS Capital and NTUitive. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A family investment firm based in Singapore, diversified across sectors.
|
Founded Year | Domain | Location | |
|
Government-backed fund investing in tech startups
|
Founded Year | Domain | Location | |
|
Startups across technologies and sectors are incubated by university-backed NTUitive.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pedra
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pedra
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pedra Comparisons
Competitors of Pedra
Pedra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Podimetrics, VOTIS, Thermetrix, Mimosa Diagnostics and Celsius Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diabetic foot ulcer monitoring device for patients and doctors
|
|
| domain | founded_year | HQ Location |
AI-based device and platform for diagnosing diabetic patient feet
|
|
| domain | founded_year | HQ Location |
Medical device design and development company
|
|
| domain | founded_year | HQ Location |
Early foot ulcer detection is facilitated by non-invasive mHealth technology.
|
|
| domain | founded_year | HQ Location |
Develops innovative devices for managing diabetic foot ulcers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pedra
Frequently Asked Questions about Pedra
When was Pedra founded?
Pedra was founded in 2013.
Where is Pedra located?
Pedra is headquartered in Singapore, Singapore.
Who is the current CEO of Pedra?
Kareen Looi is the current CEO of Pedra.
Is Pedra a funded company?
Pedra is a funded company, having raised a total of $4.7M across 2 funding rounds to date.
What does Pedra do?
Pedra was founded in 2013 in Singapore as a medical technology company. Tissue perfusion monitoring technology is provided by the firm for diagnosing and treating diabetic foot ulcers, critical limb ischemia, peripheral arterial disease, and chronic wounds. Operations focus on healthcare devices that assess blood flow in tissues, with applications in vascular medicine and wound management across clinical settings.
Who are the top competitors of Pedra?
Pedra's top competitors include Podimetrics, VOTIS and Mimosa Diagnostics.
What products or services does Pedra offer?
Pedra offers Xauron Perfusion System.
Who are Pedra's investors?
Pedra has 3 investors. Key investors include M&L Group, SEEDS Capital, and NTUitive.